Eaton Vance Worldwide Health Sciences Fund is a registered fund series of Eaton Vance Growth Trust (series S000005202). Net assets $757.9M as of 2026-05-31.
Showing 15 of 42 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Eli Lilly & Co | — | $94.5M | 1247.20% |
| AbbVie Inc | — | $48.9M | 645.53% |
| Johnson & Johnson | — | $48.9M | 644.59% |
| AstraZeneca PLC | — | $47.3M | 624.41% |
| UnitedHealth Group Inc | — | $41.6M | 548.71% |
| Roche Holding AG | — | $41.2M | 544.20% |
| Merck & Co Inc | — | $38.5M | 507.80% |
| Bristol-Myers Squibb Co | — | $32.2M | 425.25% |
| Vertex Pharmaceuticals Inc | — | $25.6M | 338.26% |
| Gilead Sciences Inc | — | $25.3M | 334.13% |
| Sanofi SA | — | $22.3M | 294.74% |
| Thermo Fisher Scientific Inc | — | $21.2M | 279.42% |
| Intuitive Surgical Inc | — | $20.6M | 271.63% |
| Stryker Corp | — | $16.8M | 221.19% |
| Boston Scientific Corp | — | $16.5M | 217.65% |
| Report date | Net assets |
|---|---|
| 2026-05-31 | $757.9M |
| 2026-02-28 | $858.0M |
| 2025-11-30 | $885.2M |
| 2025-08-31 | $834.6M |
| 2025-05-31 | $861.7M |
| 2025-02-28 | $979.9M |
| 2024-11-30 | $1.0B |
| 2024-08-31 | $1.1B |